Bisindolylmaleimide I, HCl is a water soluble form of Bisindolylmaleimide I; a staurosporine inspired molecule, which has been shown to display equally potent inhibition, but with vastly superior selectivity for all of the known isoforms of PKC (IC50 = 8-20 nM). Inhibition is competitive with respect to ATP, which suggests that Bisindolylmaleimide I occupies the ATP binding domain of the PKC isoforms. This compound has been used to selectively probe for PKC-mediated pathways for transduction of hormone, cytokine, and growth factor signals. Shown to inhibit PKC (protein kinase C) within intact platelets and T cells, Fas-mediated apoptosis, and T cell-mediated autoimmune diseases. Bisindolylmaleimide I, HCl is an inhibitor of PKC α, PKC β, PKCδ, PKC ε and PKC γ.